Clinical trials recruiting for Urothelial Carcinoma (UC)
5
Recruiting trials
29
US states with sites
14
Countries
20%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| DDI Probe Cocktail | 1 |
| Docetaxel | 1 |
| HLX18 | 1 |
| IDE397 | 1 |
| IDE892 | 1 |
| Ipilimumab | 1 |
| Nivolumab | 1 |
| Nivolumab + Relatlimab | 1 |
| Opdivo® | 1 |
| Prednisone | 1 |
| Zanzalintinib | 1 |
| [177Lu]Lu-DPI-4452 | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 2 |
| Florida | 2 |
| Nebraska | 2 |
| New Jersey | 2 |
| New York | 2 |
| Pennsylvania | 2 |
| Tennessee | 2 |
| Texas | 2 |
| Virginia | 2 |
| Arizona | 1 |
| Colorado | 1 |
| Connecticut | 1 |
Top cities
East Brunswick, New Jersey 2Irving, Texas 2Nashville, Tennessee 2New York, New York 2Omaha, Nebraska 2Philadelphia, Pennsylvania 2Tampa, Florida 2Austin, Texas 1Baltimore, Maryland 1Boston, Massachusetts 1
Self-screener
Recruiting trials
- 18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors
- A Study of HLX18 vs. OPDIVO® in Multiple Resected Solid Tumors
- A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors
- Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Related conditions
Trials recruiting for Urothelial Carcinoma (UC) often also study these conditions. Each links to its own recruiting-trial list.
Lung cancer 2180Pancreatic cancer 870Colorectal cancer 1359Non-small cell lung cancer 507Hepatocellular Carcinoma (HCC) 15Colorectal cancer 50Clear Cell Renal Cell Cancer (ccRCC) 3Breast cancer 2239Von Hippel Lindau Disease 6Triple Negative Breast Cancer (TNBC) 35
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Urothelial Carcinoma (UC) trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.